Data / Form D filings / VuEssence, Inc.
VuEssence, Inc.: Form D filings
VuEssence, Inc., a biotechnology company in Odessa, FL, filed 4 Form D notices with the SEC between 2016 and 2025. The latest, on May 12, 2025, reports $47,500 sold of a $250,000 offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 17633 GUNN HIGHWAY, STE 107, Odessa, FL, 33556
- Phone
- (813) 494-4160
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Florida
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1675398
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 12, 2025 | New notice | $250,000 | $47,500 | $202,500 | 3 | Apr 25, 2025 | sec.gov |
| Jan 14, 2020 | New notice | $2,100,000 | $1,050,000 | $1,050,000 | 1 | Dec 31, 2019 | sec.gov |
| Apr 4, 2018 | New notice | $1,500,000 | $1,500,000 | 3 | Mar 15, 2018 | sec.gov | |
| May 25, 2016 | New notice | $1,200,000 | $1,200,000 | 1 | May 18, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeffrey Barnes | Director | |
| Maha Sallam | Executive Officer, Director, Promoter | |
| Virginia Cates | Director | |
| Lorne Thomas | Director |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of May 12, 2025 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what VuEssence, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.